- Home
- RVPH vs INVE Comparison
RVPH vs INVE Comparison
Compare RVPH & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- INVE
- Stock Information
- Founded
- RVPH 2006
- INVE 1990
- Country
- RVPH United States
- INVE United States
- Employees
- RVPH 14
- INVE N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- INVE Computer peripheral equipment
- Sector
- RVPH Health Care
- INVE Technology
- Exchange
- RVPH Nasdaq
- INVE Nasdaq
- Market Cap
- RVPH 30.1M
- INVE 87.1M
- IPO Year
- RVPH N/A
- INVE 1997
- Fundamental
- Price
- RVPH $0.44
- INVE $3.62
- Analyst Decision
- RVPH Strong Buy
- INVE Strong Buy
- Analyst Count
- RVPH 4
- INVE 2
- Target Price
- RVPH $4.75
- INVE $5.50
- AVG Volume (30 Days)
- RVPH 2.0M
- INVE 41.5K
- Earning Date
- RVPH 08-14-2025
- INVE 11-06-2025
- Dividend Yield
- RVPH N/A
- INVE N/A
- EPS Growth
- RVPH N/A
- INVE N/A
- EPS
- RVPH N/A
- INVE 3.12
- Revenue
- RVPH N/A
- INVE $23,538,000.00
- Revenue This Year
- RVPH N/A
- INVE N/A
- Revenue Next Year
- RVPH N/A
- INVE $9.98
- P/E Ratio
- RVPH N/A
- INVE $1.18
- Revenue Growth
- RVPH N/A
- INVE N/A
- 52 Week Low
- RVPH $0.30
- INVE $2.86
- 52 Week High
- RVPH $4.28
- INVE $4.29
- Technical
- Relative Strength Index (RSI)
- RVPH 42.56
- INVE 46.98
- Support Level
- RVPH $0.50
- INVE $3.73
- Resistance Level
- RVPH $0.48
- INVE $3.86
- Average True Range (ATR)
- RVPH 0.03
- INVE 0.15
- MACD
- RVPH -0.00
- INVE -0.01
- Stochastic Oscillator
- RVPH 2.09
- INVE 8.57
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.